Chemopreventive effects of FITOPROT against 5-fluorouracil-induced toxicity in HaCaT cells
- PMID: 28962868
- DOI: 10.1016/j.lfs.2017.09.035
Chemopreventive effects of FITOPROT against 5-fluorouracil-induced toxicity in HaCaT cells
Abstract
Aims: This study evaluated the mechanisms involved in the chemopreventive effects of a mucoadhesive formulation (FITOPROT), containing curcuminoids from Curcuma longa L. (Zingiberaceae) and Bidens pilosa L. (Asteraceae) extract, against 5-FU-induced cellular toxicity using an in vitro oral mucositis model.
Main methods: Effects of FITOPROT on 5-FU-induced cytotoxicity in HaCaT and SSC-4 cells were evaluated by MTT assay. For mechanistic analyses, HaCaT cells were first pretreated with FITOPROT (0.005%) for 24h followed by treatment with FITOPROT and simultaneously exposed to 5-FU (10μg/mL) for additional 24h.
Key findings: FITOPROT was able to protect HaCaT cells from 5-FU-triggered cell damage. Moreover, the FITOPROT+5-FU association showed higher cytotoxic effects on SSC-4 cancer cells. Flow cytometry and/or fluorescence microscopy analysis showed FITOPROT was able to significantly reduce ROS generation and prevent mitochondrial changes in HaCaT cells. In addition, it avoided the release of cytochrome c from mitochondria to the cytoplasm in cells exposed to 5-FU, and restored their proliferative activity via Ki-67 expression. Furthermore, FITOPROT regulated 5-FU-induced oxidative stress via Nrf2 involvement. HaCaT cells pretreated/treated with FITOPROT also showed normal expression of TNF-R1 and NF-κB inflammatory proteins and decreased levels of pro-inflammatory cytokines (TNF, IL-1β, IL-6 and IL-8). Moreover, a high-resolution liquid chromatography-mass spectrometry analysis showed the presence of flavonoids rutin, glucoronylated quercetin and dimethylquercetin rutenoside in FITOPROT.
Significance: It was showed that FITOPROT, an antioxidant phytochemicals-rich mucoadhesive formulation, exerts chemopreventive effects against 5-FU-triggered toxicity through antioxidant and anti-inflammatory mechanisms and restoration of proliferative capacity in HaCaT cells.
Keywords: Bidens pilosa; Chemoprevention; Curcuma longa; Curcuminoids; Oral mucositis.
Copyright © 2017. Published by Elsevier Inc.
Similar articles
-
Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial.Support Care Cancer. 2024 Sep 2;32(9):628. doi: 10.1007/s00520-024-08842-3. Support Care Cancer. 2024. PMID: 39223301 Clinical Trial.
-
Randomized clinical trial of a mucoadhesive formulation containing curcuminoids (Zingiberaceae) and Bidens pilosa Linn (Asteraceae) extract (FITOPROT) for prevention and treatment of oral mucositis - phase I study.Chem Biol Interact. 2018 Aug 1;291:228-236. doi: 10.1016/j.cbi.2018.06.010. Epub 2018 Jun 12. Chem Biol Interact. 2018. PMID: 29906455 Clinical Trial.
-
Use of Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae) to treat intestinal mucositis in mice: Toxico-pharmacological evaluations.Toxicol Rep. 2015 Oct 30;3:279-287. doi: 10.1016/j.toxrep.2015.10.013. eCollection 2016. Toxicol Rep. 2015. PMID: 28959548 Free PMC article.
-
Effects of a mucoadhesive phytomedicine (Curcuma longa L. and Bidens pilosa L.) on radiotherapy-induced oral mucositis and quality of life of patients undergoing head and neck cancer treatment: randomized clinical trial.Support Care Cancer. 2023 Aug 11;31(9):517. doi: 10.1007/s00520-023-07971-5. Support Care Cancer. 2023. PMID: 37566179 Clinical Trial.
-
Biological effects of formulation containing curcuminoids and Bidens Pilosa L. in oral carcinoma cell line.Braz Oral Res. 2021 May 31;35:e063. doi: 10.1590/1807-3107bor-2021.vol35.0063. eCollection 2021. Braz Oral Res. 2021. PMID: 34076188
Cited by
-
In vitro cytoprotective and in vivo anti-oral mucositis effects of melatonin and its derivatives.PeerJ. 2024 Jul 5;12:e17608. doi: 10.7717/peerj.17608. eCollection 2024. PeerJ. 2024. PMID: 38978756 Free PMC article.
-
Topical Treatment of Oral Mucositis in Cancer Patients: A Systematic Review of Randomized Clinical Trials.Asian Pac J Cancer Prev. 2020 Jul 1;21(7):1851-1866. doi: 10.31557/APJCP.2020.21.7.1851. Asian Pac J Cancer Prev. 2020. PMID: 32711408 Free PMC article.
-
The Intestinal Redox System and Its Significance in Chemotherapy-Induced Intestinal Mucositis.Oxid Med Cell Longev. 2022 May 9;2022:7255497. doi: 10.1155/2022/7255497. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35585883 Free PMC article. Review.
-
Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial.Support Care Cancer. 2024 Sep 2;32(9):628. doi: 10.1007/s00520-024-08842-3. Support Care Cancer. 2024. PMID: 39223301 Clinical Trial.
-
Immunomodulatory Properties of Natural Extracts and Compounds Derived from Bidens pilosa L.: Literature Review.Pharmaceutics. 2023 May 13;15(5):1491. doi: 10.3390/pharmaceutics15051491. Pharmaceutics. 2023. PMID: 37242733 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources